Heart Disease Clinical Trials in San Antonio

Showing 41-60 of 318 trials

Ketones, SGLT2, HFrEF

NCT06229678

The study team will examine the effects of elevated plasma ketone levels following initiation of SGLT2 inhibitor therapy in high-risk type 2 diabetes mellitus (T2DM) individuals with heart failure (HF) with reduced ejection fraction (HFrEF) providing an energy-rich fuel that is taken up with great avidity by the myocardium, to measure change in Left Ventricle diastolic and systolic function

Type2diabetesHeart Failure With Reduced Ejection Fraction

The University of Texas Health Science Center at San Antonio71 participantsStarted Jan 2024

San Antonio, Texas, United States

Active Not Recruiting< 1 mile

Equity in Modifying Plaque Of WomEn With UndeRtreated Calcified Coronary Artery Disease

NCT05755711

Post-market, prospective, multi-center, single-arm observational study to generate real-world clinical evidence associated with coronary IVL in a population of female subjects with calcified coronary artery disease.

Coronary Artery Disease

Shockwave Medical, Inc.399 participantsStarted May 2023

Loma Linda, California, United States • Los Angeles, California, United States • San Francisco, California, United States +46 more locations

Ketones, SGLT2, HFrEF

Equity in Modifying Plaque Of WomEn With UndeRtreated Calcified Coronary Artery Disease

Heart Disease Trials in Other Cities

A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With Clinical ASCVD or at Risk for a First ASCVD Event

Assessment of CCM in HF With Higher Ejection Fraction

Lifestyle Intervention for Heart Failure

ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack

A Study of Vericiguat (MK-1242) in Participants With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-035)

SyncAV Post-Market Trial

Aventus Thrombectomy System Pulmonary Embolism Clinical Study

Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products

A Study of LY3540378 in Participants With Worsening Chronic Heart Failure With Preserved Ejection Fraction (HFpEF)

Comparison of Methods of Pulmonary Blood Flow Augmentation in Neonates: Shunt Versus Stent (The COMPASS Trial)

STeroids to REduce Systemic Inflammation After Infant Heart Surgery

A Extension Study of Udenafil in Adolescents

Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258)

Research Study to Look at How Well Semaglutide Works in People Living With Heart Failure, Obesity and Type 2 Diabetes

Algorithm Using LINQ Sensors for Evaluation And Treatment of Heart Failure

PIONEER III Trial to Assess Safety and Efficacy of the BuMA Supreme™ Drug Coated Coronary Stent in Patients With Coronary Disease

A Feasibility Study of the Millipede Transcatheter Annuloplasty Ring System in Patients With Functional Mitral Regurgitation

Diabetes-Centered Evaluation of Revascularization Strategy of Functional and Imaging-CombiNEd State-of-the-Art Percutaneous Coronary Intervention or Coronary-Artery Bypass Grafting in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease

Other Conditions in San Antonio